Cite
HARVARD Citation
Perry, M. et al. (2018). Method Comparison Between ELISAs Suggests Therapeutic Ranges for Infliximab Should Be Assay-Specific. Journal of applied laboratory medicine. pp. 515-517. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Perry, M. et al. (2018). Method Comparison Between ELISAs Suggests Therapeutic Ranges for Infliximab Should Be Assay-Specific. Journal of applied laboratory medicine. pp. 515-517. [Online].